Arizona State Retirement System’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-27,425
Closed -$3.62M – 2128
2025
Q1
$3.62M Sell
27,425
-140
-0.5% -$17.4K 0.02% 512
2024
Q4
$2.3M Buy
27,565
+206
+0.8% +$16.9K 0.01% 698
2024
Q3
$2M Buy
27,359
+2,947
+12% +$221K 0.01% 761
2024
Q2
$1.67M Buy
24,412
+608
+3% +$42.2K 0.01% 791
2024
Q1
$1.65M Sell
23,804
-372
-2% -$25.6K 0.01% 815
2023
Q4
$1.73M Sell
24,176
-405
-2% -$23.3K 0.01% 769
2023
Q3
$1.28M Buy
24,581
+495
+2% +$28.8K 0.01% 864
2023
Q2
$1.53M Sell
24,086
-611
-2% -$38.1K 0.01% 789
2023
Q1
$1.34M Buy
24,697
+723
+3% +$35K 0.01% 841
2022
Q4
$1.27M Buy
23,974
+905
+4% +$45.4K 0.01% 853
2022
Q3
$1.07M Buy
23,069
+550
+2% +$28.7K 0.01% 888
2022
Q2
$1.28M Buy
22,519
+383
+2% +$21.7K 0.01% 825
2022
Q1
$1.35M Buy
22,136
+3,527
+19% +$183K 0.01% 893
2021
Q4
$974K Sell
18,609
-192
-1% -$8.06K 0.01% 1115
2021
Q3
$701K Buy
18,801
+105
+0.6% +$3.65K 0.01% 1325
2021
Q2
$763K Sell
18,696
-2,305
-11% -$85.2K 0.01% 1295
2021
Q1
$713K Buy
21,001
+389
+2% +$13.5K 0.01% 1333
2020
Q4
$655K Buy
20,612
+2,567
+14% +$67.5K 0.01% 1316
2020
Q3
$463K Buy
18,045
+4,496
+33% +$103K ﹤0.01% 1360
2020
Q2
$348K Sell
13,549
-240
-2% -$4.86K ﹤0.01% 1330
2020
Q1
$212K Buy
+13,789
New +$299K ﹤0.01% 1483

Other funds holding ITCI

Arizona State Retirement System's ITCI Position: Q2 2025 in Review

Arizona State Retirement System sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 27,425 shares — an estimated $3.62M sold.

Arizona State Retirement System first reported a position in ITCI in Q1 2020 and held it in 21 quarters. The position peaked at $3.62M in Q1 2025. 3 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Arizona State Retirement System reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 27,425 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $3.62M.
  • Arizona State Retirement System first reported a position in Intra-Cellular Therapies Inc. in Q1 2020 and held it in 21 quarters.
  • Arizona State Retirement System's Intra-Cellular Therapies Inc. position peaked at $3.62M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Arizona State Retirement System's 13F filing for Q2 2025, filed 13 Aug 2025.